2025 marked record-high lobbying expenditures by the pharmaceutical industry, with PhRMA spending nearly $38 million and total healthcare lobbying surging 16% to $653 million in the first three quarters, underscoring intensified influence amid regulatory shifts. Confirmed reverse revolving door appointments include Chainlink's Taylor Lindman as SEC Crypto Task Force Chief Counsel in February 2026 and Nancy Beck's ongoing senior role at EPA's chemical safety office; former Energy Secretary Jennifer Granholm expanded to Edison International's board alongside her DGA Group position. No major new forward revolving door placements for figures like ex-SEC Chair Gary Gensler as of March 2026, but the pattern persists with legislative efforts like H.R.3554 to curb it.
2026-03-20 09:06 UTC
paused